Autopsy report · NCT03317665

Observational Biologic or Prosthetic Mesh

“Premature termination due to cease of funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 4 months before it started.
• Ran for about 2 years 4 months before it stopped.
• 28 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

University of South Florida

Sponsor type

University, hospital or other

Conditions

Ventral Incisional Hernia

Interventions

Mesh for hernia repair

Participants

28

Sites

3

Countries

United States

Trials that died the same way

• Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
  “Funding Termination” (86% match in meaning)
• Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
  “Terminated due to insufficient funding” (78% match in meaning)
• Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
  “Terminated due to loss of funding” (77% match in meaning)
• Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
  “Funding ended prematurely” (77% match in meaning)
• Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
  “Terminated due to loss in funding” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.